3 Results for "

EGFR kinase inhibitor4

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "EGFR kinase inhibitor4" in MCE Product Catalog:

Cat. No.: HY-162300
CAS No.: 2922402-05-7
Target:  

EGFR

Research Areas:  

Cancer

EGFR kinase inhibitor 4 (Compound 4) is a bivalent ATP-allosteric EGFR inhibitor (IC50: 1.8 nM for mutant EGFR (LRTMCS)). EGFR kinase inhibitor 4 can be used for research of NSCLC .
loading...
    loading...
Cat. No.: HY-129510
CAS No.: 1346601-52-2
Target:  

EGFR Mitosis

Research Areas:  

Cancer

4-Methyl erlotinib, is a potent and selective epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor. 4-Methyl erlotinib potently inhibits EGF-mediated tumor cell mitosis by reducing EGFr-specific tyrosine phosphorylation. Using a mouse model of human tumor transplantation, 4-Methyl erlotinib demonstrated significant and sustained suppression of EGFr phosphotyrosine levels, resulting in significant growth inhibition of EGFr-dependent human cancers .
loading...
    loading...
Cat. No.: HY-129510R
CAS No.: 1346601-52-2
Research Areas:  

Cancer

4-Methyl erlotinib (Standard) is the analytical standard of 4-Methyl erlotinib. This product is intended for research and analytical applications. 4-Methyl erlotinib, is a potent and selective epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor. 4-Methyl erlotinib potently inhibits EGF-mediated tumor cell mitosis by reducing EGFr-specific tyrosine phosphorylation. Using a mouse model of human tumor transplantation, 4-Methyl erlotinib demonstrated significant and sustained suppression of EGFr phosphotyrosine levels, resulting in significant growth inhibition of EGFr-dependent human cancers .
loading...
    loading...